Key result
Indomethacin increases mean blood pressure by ~9 mmHg versus placebo in treated hypertensive patients.
RCT (n=12)
Double-blind
Randomized crossover
Answers are grounded in this paper and cite their sources.
Randomized double-blind trial shows indomethacin raises blood pressure in treated hypertensive patients, indicating impaired antihypertensive efficacy.
Twelve treated hypertensive patients (ages 58-71 years) who had also been treated for joint disease participated in a randomized double-blind crossover placebo-controlled study to investigate the effects of indomethacin (25 mg three times daily) on blood pressure and biochemical parameters over a 6-week period. 2. Blood pressure was increased in all patients throughout the indomethacin treatment period (P less than 0.001)--average mean blood pressure increases were 9 mmHg (casual), 8 mmHg (supine), 10 mmHg (standing). 3. The blood pressure increase during indomethacin treatment was independent of the particular antihypertensive regimen in use. 4. Plasma aldosterone concentration was reduced by 50% (P less than 0.01), plasma renin activity was reduced by 43% (P = 0.102) and plasma urea concentration was increased by 17% (P less than 0.001) during indomethacin treatment. 5. The findings confirm that indomethacin impairs the blood pressure lowering effect of antihypertensive regimens.
No takes yet. Share an insight, caveat, or question.
Wing et al. (1981) conducted an RCT in Treated hypertension and joint disease (n=12). Indomethacin vs. Placebo was evaluated on Mean blood pressure (casual, supine, and standing) (MD 9 mmHg (casual), 8 mmHg (supine), 10 mmHg (standing), p=<0.001). Indomethacin increased mean blood pressure by 8-10 mmHg compared to placebo in treated hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: